Cerenome, Inc. (CNSY)
1.71
-0.03
(-1.72%)
USD |
NASDAQ |
Oct 29, 16:00
1.75
+0.04
(+2.34%)
After-Hours: 20:00
Cerenome Price : 1.71 for Oct. 29, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 28, 2026 | 1.71 | 1.82 | 1.666 | 1.74 | 46300.00 |
| Oct 27, 2026 | 1.58 | 1.69 | 1.52 | 1.66 | 51152.00 |
| Oct 26, 2026 | 1.65 | 1.65 | 1.51 | 1.57 | 74046.00 |
| Oct 23, 2026 | 1.78 | 1.78 | 1.63 | 1.64 | 62575.00 |
| Oct 22, 2026 | 1.75 | 1.835 | 1.71 | 1.75 | 43136.00 |
| Oct 21, 2026 | 1.65 | 1.80 | 1.65 | 1.73 | 53822.00 |
| Oct 20, 2026 | 1.59 | 1.77 | 1.575 | 1.68 | 76921.00 |
| Oct 19, 2026 | 1.72 | 1.72 | 1.602 | 1.65 | 47382.00 |
| Oct 16, 2026 | 1.91 | 1.96 | 1.70 | 1.70 | 85065.00 |
| Oct 15, 2026 | 1.66 | 1.92 | 1.66 | 1.88 | 111762.0 |
| Oct 14, 2026 | 1.76 | 1.76 | 1.55 | 1.69 | 82191.00 |
| Oct 13, 2026 | 1.80 | 1.81 | 1.639 | 1.74 | 116517.0 |
| Oct 12, 2026 | 1.92 | 1.92 | 1.80 | 1.81 | 52356.00 |
| Oct 09, 2026 | 1.80 | 1.96 | 1.795 | 1.93 | 152159.0 |
| Oct 08, 2026 | 1.68 | 1.80 | 1.60 | 1.79 | 122726.0 |
| Oct 07, 2026 | 1.62 | 1.71 | 1.56 | 1.635 | 110931.0 |
| Oct 06, 2026 | 1.56 | 1.66 | 1.54 | 1.59 | 69638.00 |
| Oct 05, 2026 | 1.52 | 1.59 | 1.485 | 1.56 | 222893.0 |
| Oct 02, 2026 | 1.81 | 1.86 | 1.54 | 1.60 | 234618.0 |
| Oct 01, 2026 | 1.94 | 2.280 | 1.64 | 1.78 | 1.169M |
| Sep 30, 2026 | 2.02 | 2.02 | 1.84 | 1.87 | 226526.0 |
| Sep 29, 2026 | 2.03 | 2.12 | 1.86 | 1.86 | 240878.0 |
| Sep 28, 2026 | 1.99 | 2.06 | 1.90 | 2.02 | 99108.00 |
| Sep 25, 2026 | 1.92 | 2.080 | 1.92 | 1.99 | 204235.0 |
| Sep 24, 2026 | 1.96 | 1.96 | 1.86 | 1.87 | 86042.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 173.90 |
| Ernexa Therapeutics, Inc. | 1.98 |
| ACADIA Pharmaceuticals, Inc. | 20.76 |
| Anika Therapeutics, Inc. | 21.77 |
| Savara, Inc. | 4.955 |
Price Related Metrics
| PS Ratio | 2.379 |
| Price to Book Value | 2.288 |
| Earnings Yield | -257.9% |
| Market Cap | 12.50M |